Physician

Mark Adam Theodore Molckovsky, MD

According to 2025 Medicare claims, Mark Molckovsky, MD (NPI: 1356705768) practices family practice in the State College, PA market, with the plurality of this provider's patient population coming from Centre, PA. This provider's primary affiliated billing organization is CLEARFIELD-JEFFERSON PRIMARY CARE ASSOCIATES PC (NPI: 1710233895; TIN: 460627085) and primary practice location at 16801-4516.

Molckovsky's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 415 traditional Medicare patients, billed 1,493 HCPCS/CPT codes, and received $133,981 in Medicare payments. The top billing code was 99310 (Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes). Part D data shows 2,054 prescription claims across 340 beneficiaries totaling $160,774 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 12 claims. Open Payments data shows 1 records totaling $77. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $95 to $133,981. Similarly, Part D prescription costs have moved sharply higher in recent years, from $3,011 to $160,774. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	12	18	$95
2020	32	46	$225
2021	20	28	$450
2022	53	71	$482
2023	16	21	$127
2024	415	1,493	$133,981

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	16	29	$3,011
2017	46	80	$5,432
2018	83	199	$17,336
2019	90	261	$18,323
2020	205	1,013	$112,087
2021	261	1,754	$160,367
2022	361	2,879	$316,473
2023	219	1,858	$230,429
2024	340	2,054	$160,774

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	13	$138
2021	N/R	12	$88
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99310	Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes	97	127	$115
99349	Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes	77	252	$96
99309	Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes	181	312	$82
99497	Advance care planning, first 30 minutes	82	91	$58
99308	Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more	132	198	$57

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	50	1,676	$33,819
Jardiance	Empagliflozin	14	397	$8,390
Divalproex Sodium	Divalproex Sodium	19	510	$2,543
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	390	$2,048
Potassium Chloride	Potassium Chloride	33	1,060	$1,578

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$77	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark Adam Theodore Molckovsky, MD?

Tedicare shows public-source Medicare data for Mark Adam Theodore Molckovsky, MD (NPI 1356705768), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Adam Theodore Molckovsky, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark Adam Theodore Molckovsky, MD?

Mark Adam Theodore Molckovsky, MD is linked to CLEARFIELD-JEFFERSON PRIMARY CARE ASSOCIATES PC (billing NPI 1710233895) in the available physician profile data.

Does Mark Adam Theodore Molckovsky, MD have Open Payments data?

Mark Adam Theodore Molckovsky, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.